Inventor · disambiguated record
Masahide Aoki
Also filed as: AOKI MASAHIDE
8 granted patents·2 pending applications·21 citations·filing 2017–2025
82Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD10
Top patents by PatentIndex Score
10 records- 0196US10858356B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 8, 2020·18 cites·17 claims
- 0295US11814381B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 14, 2023·3 cites·1 claims
- 0390US12331050B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Jun 17, 2025·0 cites·18 claims
- 0489US12331049B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Jun 17, 2025·0 cites·3 claims
- 0589US2025092041A1Pyrazolopyridine derivative having glp-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0688US12410168B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Granted Sep 9, 2025·0 cites·11 claims
- 0787US12187724B2Pyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Jan 7, 2025·0 cites·3 claims
- 0870USRE50455EPyrazolopyridine derivative having GLP-1 receptor agonist effectCHUGAI PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 10, 2025·0 cites·41 claims
- 0959US12312379B2Methods for producing cyclic compounds comprising N-substituted amino acid residuesCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted May 27, 2025·0 cites·28 claims
- 1056US2025257094A1Methods for producing cyclic compounds comprising n-substituted amino acid residuesCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masahide Aoki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →